Author

E. B. Vitner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Organism:human· 1

Frequent Co-Authors

B. Politi· 4 shared S. Melamed· 4 shared T. Israely· 4 shared H. Achdout· 3 shared A. Beth-Din· 2 shared H. Tamir· 2 shared L. Cherry· 2 shared N. Erez· 2 shared

Activity by Year

2020-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

B. Politi

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection

A. E. Chaouat, H. Achdout, I. Kol, O. Berhani, G. Roi, E. B. Vitner, S. Melamed, B. Politi, E. Zahavi, I. Brizic, T. Lenac Rovis, O. B. Alfi, D. Wolf, S. Jonjic, T. Israely, O. Mandelboim

This paper develops RBD-Ig fusion proteins that efficiently neutralize SARS-CoV-2 infection in vitro and in vivo, outperforming ACE2-Ig.

bioRxiv · Apr 18, 2021Immunology

Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody

R. Rosenfeld, T. Noy-Porat, A. Mechaly, E. Makdasi, Y. Levy, R. Alcalay, R. Falach, M. Aftalion, E. Epstein, D. Gur, T. Chitlaru, E. B. Vitner, S. Melamed, B. Politi, A. Zauberman, , O. Mazor

This study shows that the human monoclonal antibody MD65 can rescue 100% of SARS-CoV-2 infected mice when administered up to 3 days post-exposure.

bioRxiv · Oct 26, 2020Immunology

A single dose of recombinant VSV-{triangleup}G-spike vaccine provides protection against SARS-CoV-2 challenge

Y. Yahalom-Ronen, H. Tamir, S. Melamed, B. Politi, O. Shifman, H. Achdout, E. B. Vitner, O. Israeli, E. Milrot, D. Stein, I. Cohen-Gihon, S. Lazar, H. Gutman, I. Glinert, L. Cherry, , T. Israely

This study develops a recombinant VSV-ΔG-spike vaccine that provides single-dose protection against SARS-CoV-2 in hamsters by inducing neutralizing antibodies and preventing lung pathology.

bioRxiv · Jun 18, 2020Microbiology

Antiviral activity of Glucosylceramide synthase inhibitors against SARS-CoV-2 and other RNA virus infections

E. B. Vitner, R. Avraham, H. Achdout, H. Tamir, A. Agami, L. Cherry, Y. Yahalom-Ronen, B. Politi, N. Erez, S. Melamed, N. Paran, T. Israely

The study evaluates two GCS inhibitors for antiviral activity against four enveloped RNA viruses, including SARS-CoV-2, showing broad-spectrum efficacy and improved survival in infected mice.

bioRxiv · May 18, 2020 · PreprintMicrobiology